引文：Meijuan Huang, Youling Gong, Jiang Zhu, Yi Qin, Feng Peng, Li Ren, Zhenyu Ding, Yongmei Liu, Chengzhi Cai, Yongsheng Wang, You Lu. A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC. Invest New Drugs. 2019; 38: 478-484.
川公网安备51010702002012
